Vincerx Pharma Stock Price Prediction
| VINC Stock | USD 0.19 0.01 5.00% |
Oversold Vs Overbought
36
Oversold | Overbought |
EPS Estimate Next Quarter (0.20) | EPS Estimate Current Year (0.73) | EPS Estimate Next Year (0.67) | Wall Street Target Price 6 |
Using Vincerx Pharma hype-based prediction, you can estimate the value of Vincerx Pharma from the perspective of Vincerx Pharma response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Vincerx Pharma to buy its stock at a price that has no basis in reality. In that case, they are not buying Vincerx because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Vincerx Pharma after-hype prediction price | USD 0.17 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Vincerx |
Vincerx Pharma After-Hype Price Prediction Density Analysis
As far as predicting the price of Vincerx Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Vincerx Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Vincerx Pharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Vincerx Pharma Estimiated After-Hype Price Volatility
In the context of predicting Vincerx Pharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Vincerx Pharma's historical news coverage. Vincerx Pharma's after-hype downside and upside margins for the prediction period are 0.01 and 7.09, respectively. We have considered Vincerx Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Vincerx Pharma is extremely dangerous at this time. Analysis and calculation of next after-hype price of Vincerx Pharma is based on 3 months time horizon.
Vincerx Pharma Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Vincerx Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Vincerx Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Vincerx Pharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.73 | 6.93 | 0.02 | 0.56 | 5 Events / Month | 5 Events / Month | In about 5 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.19 | 0.17 | 10.53 |
|
Vincerx Pharma Hype Timeline
Vincerx Pharma is at this time traded for 0.19. The entity has historical hype elasticity of -0.02, and average elasticity to hype of competition of 0.56. Vincerx is estimated to decline in value after the next headline, with the price expected to drop to 0.17. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -10.53%, whereas the daily expected return is at this time at -1.73%. The volatility of related hype on Vincerx Pharma is about 2127.63%, with the expected price after the next announcement by competition of 0.75. About 18.0% of the company outstanding shares are owned by insiders. The company has Price to Book (P/B) ratio of 0.68. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Vincerx Pharma recorded a loss per share of 1.14. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next estimated press release will be in about 5 days. Check out Vincerx Pharma Basic Forecasting Models to cross-verify your projections.Vincerx Pharma Related Hype Analysis
Having access to credible news sources related to Vincerx Pharma's direct competition is more important than ever and may enhance your ability to predict Vincerx Pharma's future price movements. Getting to know how Vincerx Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Vincerx Pharma may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| PBYI | Puma Biotechnology | 0.02 | 7 per month | 4.56 | 0.05 | 5.17 | (5.60) | 33.65 | |
| IOVA | Iovance Biotherapeutics | (0.45) | 9 per month | 0.00 | (0.07) | 7.54 | (7.12) | 23.06 | |
| DAWN | Day One Biopharmaceuticals | 0.62 | 10 per month | 0.00 | (0.07) | 3.71 | (3.69) | 11.05 | |
| INZY | Inozyme Pharma | (0.32) | 8 per month | 0.00 | (0.25) | 5.84 | (7.92) | 16.32 | |
| ZNTL | Zentalis Pharmaceuticals Llc | (0.29) | 10 per month | 5.41 | 0.01 | 11.41 | (8.71) | 33.76 | |
| SNDX | Syndax Pharmaceuticals | (0.46) | 9 per month | 0.00 | (0.09) | 4.02 | (5.34) | 34.00 | |
| PTGX | Protagonist Therapeutics | 3.16 | 7 per month | 0.00 | (0.08) | 3.42 | (3.82) | 16.19 |
Vincerx Pharma Additional Predictive Modules
Most predictive techniques to examine Vincerx price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Vincerx using various technical indicators. When you analyze Vincerx charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Vincerx Pharma Predictive Indicators
The successful prediction of Vincerx Pharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Vincerx Pharma, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Vincerx Pharma based on analysis of Vincerx Pharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Vincerx Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Vincerx Pharma's related companies.
Story Coverage note for Vincerx Pharma
The number of cover stories for Vincerx Pharma depends on current market conditions and Vincerx Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Vincerx Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Vincerx Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Vincerx Pharma Short Properties
Vincerx Pharma's future price predictability will typically decrease when Vincerx Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Vincerx Pharma often depends not only on the future outlook of the potential Vincerx Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Vincerx Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 21.3 M | |
| Cash And Short Term Investments | 12.8 M |
Complementary Tools for Vincerx Stock analysis
When running Vincerx Pharma's price analysis, check to measure Vincerx Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vincerx Pharma is operating at the current time. Most of Vincerx Pharma's value examination focuses on studying past and present price action to predict the probability of Vincerx Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vincerx Pharma's price. Additionally, you may evaluate how the addition of Vincerx Pharma to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |